|
|
|
Insider
Information: |
Baum Mark L |
Relationship: |
Director |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
18,874,371 |
|
Indirect Shares
|
2,432,206 |
|
|
Direct
Value |
$40,886,133 |
|
|
Indirect Value
|
$9,533,343 |
|
|
Total
Shares |
21,306,577 |
|
|
Total
Value |
$50,419,476 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-9.8%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chembio Diagnostics Inc |
CEMI |
Officer, Director, 10%... |
2003-12-20 |
15,000,000 |
|
0 |
Premium* |
|
Quest Oil Corp |
QOIL |
General Counsel |
2006-10-03 |
0 |
2006-08-28 |
490,000 |
Premium* |
|
Shrink Nanotechnologies Inc |
INKN |
Chief Executive Office... |
2006-11-13 |
34,262 |
2010-10-20 |
1,305,017 |
Premium* |
|
Protokinetix Inc |
PKTX |
Officer, Director |
2007-05-28 |
826,091 |
|
0 |
Premium* |
|
Png Ventures Inc |
PNGXQ |
Officer, Director |
2008-05-20 |
65,850 |
|
0 |
Premium* |
|
Harrow Health Inc |
HROW |
CHIEF EXECUTIVE OFFICE... |
2024-03-22 |
2,137,525 |
2019-11-22 |
598,126 |
Premium* |
|
Ideal Power Inc. |
IPWR |
Director |
2015-11-13 |
25,898 |
2015-11-13 |
29,063 |
Premium* |
|
Eton Pharmaceuticals, Inc. |
ETON |
Director |
2018-11-15 |
784,745 |
2018-11-15 |
10,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
53 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
INKN |
Shrink Nanotechnologies I... |
PresidentChief Executive Offic |
|
2009-03-24 |
5 |
A |
$1.02 |
$3,060 |
I/I |
3,000 |
3,000 |
0 |
- |
|
INKN |
Shrink Nanotechnologies I... |
PresidentChief Executive Offic |
|
2009-06-23 |
5 |
A |
$1.16 |
$1,164 |
I/I |
1,000 |
1,000 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2012-02-28 |
5 |
A |
$0.00 |
$0 |
I/I |
1,454,962 |
0 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2012-04-30 |
5 |
A |
$762,534.00 |
$2,147,483,647 |
I/I |
193,047 |
0 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2012-06-29 |
4 |
A |
$0.00 |
$0 |
I/I |
7,498,500 |
15,738,545 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2012-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
846,927 |
846,927 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2012-07-18 |
4 |
A |
$0.00 |
$0 |
D/D |
800,000 |
1,646,927 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2013-05-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,250,000 |
1,419,835 |
0 |
- |
|
IPWR |
Ideal Power Inc. |
|
|
2013-11-27 |
4 |
A |
$3.48 |
$101,139 |
I/I |
29,063 |
29,063 |
0 |
- |
|
IPWR |
Ideal Power Inc. |
|
|
2014-01-03 |
4 |
A |
$5.00 |
$54,305 |
D/D |
10,861 |
54,961 |
0 |
- |
|
IPWR |
Ideal Power Inc. |
|
|
2014-01-03 |
4 |
A |
$5.00 |
$54,305 |
D/D |
10,861 |
54,961 |
0 |
- |
|
INKN |
Shrink Nanotechnologies I... |
Chief Executive Officer |
|
2010-10-13 |
4 |
AS |
$0.14 |
$42,900 |
I/I |
(300,000) |
2,200,000 |
0 |
- |
|
INKN |
Shrink Nanotechnologies I... |
Chief Executive Officer |
|
2010-10-14 |
4 |
AS |
$0.01 |
$3,861 |
I/I |
(270,000) |
1,930,000 |
0 |
- |
|
INKN |
Shrink Nanotechnologies I... |
Chief Executive Officer |
|
2010-10-15 |
4 |
AS |
$0.14 |
$14,000 |
I/I |
(100,000) |
1,830,000 |
0 |
- |
|
INKN |
Shrink Nanotechnologies I... |
Chief Executive Officer |
|
2010-10-18 |
4 |
AS |
$0.15 |
$15,100 |
I/I |
(100,000) |
1,730,000 |
0 |
- |
|
INKN |
Shrink Nanotechnologies I... |
Chief Executive Officer |
|
2010-10-20 |
4 |
AS |
$0.12 |
$50,148 |
I/I |
(424,983) |
1,305,017 |
0 |
- |
|
QOIL |
Quest Oil Corp |
General Counsel |
|
2006-08-28 |
4 |
B |
$0.00 |
$0 |
I/I |
187,500 |
490,000 |
0.01 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2016-12-19 |
4 |
B |
$1.79 |
$279,240 |
D/D |
156,000 |
325,835 |
2.81 |
- |
|
ETON |
Eton Pharmaceuticals, Inc... |
Director |
|
2018-11-15 |
4 |
B |
$6.00 |
$60,000 |
I/I |
10,000 |
10,000 |
2.1 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2023-08-14 |
4 |
B |
$17.05 |
$98,890 |
D/D |
5,800 |
2,015,461 |
2.81 |
% |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2023-11-16 |
4 |
B |
$8.11 |
$60,825 |
D/D |
7,500 |
2,022,961 |
2.81 |
% |
|
HROW |
Harrow Health Inc |
CHIEF EXECUTIVE OFFICER |
|
2024-03-22 |
4 |
B |
$11.59 |
$104,310 |
D/D |
9,000 |
2,137,525 |
2.81 |
% |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2016-12-19 |
4 |
D |
$1.72 |
$143,979 |
D/D |
(83,709) |
442,126 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2021-04-25 |
4 |
D |
$8.26 |
$2,759,906 |
D/D |
(334,129) |
1,353,547 |
0 |
- |
|
HROW |
Harrow Health Inc |
Chief Executive Officer |
|
2022-01-20 |
4 |
D |
$8.33 |
$594,812 |
D/D |
(71,406) |
1,407,141 |
0 |
- |
|
53 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|